scispace - formally typeset
M

Michel Redonnet

Researcher at University of Rouen

Publications -  18
Citations -  669

Michel Redonnet is an academic researcher from University of Rouen. The author has contributed to research in topics: Heart transplantation & Transplantation. The author has an hindex of 12, co-authored 18 publications receiving 636 citations.

Papers
More filters
Journal ArticleDOI

Coarctation of the aorta in adults: surgical results and long-term follow-up.

TL;DR: Surgical repair of coarctation in adults has proved to be an effective procedure and significantly reduces arterial hypertension, however, long-term surveillance is mandatory and should include exercise testing to identify patients with potential hypertension.
Journal ArticleDOI

Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.

TL;DR: Basiliximab offers improved tolerability with similar efficacy compared with current polyclonal antibody induction therapy in de novo heart transplant patients, and this 6-month, prospective, randomized, multicenter, open-label study examined whether basiliximrab offers a tolerability benefit compared with anti-thymocyte globulin.
Journal ArticleDOI

Dobutamine stress echocardiography in orthotopic heart transplant recipients

TL;DR: Preliminary results indicate that dobutamine stress echocardiography may have a predictive value for further ischemic events in heart transplant recipients and is a useful technique for the diagnosis of coronary artery disease after heart transplantation.
Journal ArticleDOI

Catheter ablation of atrioatrial conduction as a cure for atrial arrhythmia after orthotopic heart transplantation.

TL;DR: The existence of arrhythmogenic atrioatrial conduction should be taken into account when evaluating atrial arrhythias in the transplanted heart because it is potentially curable by radiofrequency catheter ablation.
Journal Article

Assessment of the progression of cardiac allograft vasculopathy by Dobutamine stress echocardiography

TL;DR: Dobutamine stress echocardiography is a sensitive, noninvasive method to diagnose the progression of allograft vasculopathy, and a negative test result is a strong predictor of absence ofallograft coronary vasculopathic disease.